Bubs share price slides despite ‘get back on track’ update

Bubs has announced the results of its strategic review.

| More on:
Young woman dressed in suit sitting at cafe staring at laptop screen with hands to her forehead looking tense

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • Bubs has announced the results of its strategic review
  • The infant formula company has laid out its five-point plan to undo the damage left by its previous leadership and return to growth
  • The company has also provided guidance for FY 2024

The Bubs Australia Ltd (ASX: BUB) share price is falling on Thursday despite a big announcement.

In morning trade, the infant formula company’s shares were down almost 9% to 20.5 cents.

The Bubs share price has retraced some of this decline and currently sits a touch over 4.5% lower at 21.5 cents.

What’s going on with the Bubs share price today?

This morning, Bubs announced the results of its hotly anticipated strategic review.

This review was put in place by the company’s new management team in response to the failings of its previous (now removed) leadership.

Bubs’ Chair, Katrina Rathie, unveiled a five-point plan which aims to “responsibly manage capital and to grow and maximise shareholder value.”

This comprises resetting the China business, optimising its portfolio, pushing for further growth in the United States, sweating existing assets, and cutting costs.

In respect to the latter, the company expects to reduce its monthly cash burn by more than half to $2 million a month from the second quarter of FY 2024.

Whereas in China, a reset has now commenced with a multi-channel go-to-market strategy under new leadership and new trade partners. The company intends to focus on where it has a competitive advantage – goat infant milk formula and goat adult milk powder.

Bubs’ recently appointed independent non-executive director, Reg Weine, was tasked with leading the review. He commented:

We must immediately arrest the decline in shareholder value and get Bubs back on track. Capitalising on our first mover advantage in the US and resetting China are two significant components of our strategic plan. We have a clear competitive advantage in goat infant and adult nutrition, and we need to focus our efforts on this part of our portfolio. With a greater focus on working capital, and tighter control on costs, we will quickly reduce the monthly cash burn, extend the runway, and deliver sustainable shareholder value.

Outlook

Bubs has also provided guidance for FY 2024 with today’s update. It expects the following:

  • Net sales revenue of $80 million (up 35% on the previous year)
  • Gross profit margin of 40%
  • Working capital improvements

Management also advised that it expects to be cash flow positive in FY 2025.

Why is the Bubs share price falling?

While the above reads very positively, it appears to have already been largely priced into the Bubs share price after a huge jump on Wednesday.

Potentially in anticipation of the update today, investors bid Bubs shares almost 20% higher yesterday.

However, despite this, they are still down over 60% since this time last year. Shareholders will no doubt be hoping that these actions put its shares on the right path again.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Consumer Staples & Discretionary Shares

A woman screams and holds her hands up in frustration.
Earnings Results

Baby Bunting share price sinks 10% as profits crash

Baby Bunting has reported a huge decline in its profits today.

Read more »

A male sharemarket analyst sits at his desk looking intently at his laptop with two other monitors next to him showing stock price movements
Consumer Staples & Discretionary Shares

Here’s what a top broker is saying about A2 Milk shares

Is this infant formula a buy? Let's see what a top broker is saying.

Read more »

A woman is excited as she reads the latest rumour on her phone.
Earnings Results

Cettire share price jumps 11% on dazzling FY23 growth

Consumer spending weakness hasn't been able to stop Cettire's rapid growth.

Read more »

A woman sits at her computer with her hand to her mouth and a contemplative smile on her face as she reads about the performance of Allkem shares on her computer
Consumer Staples & Discretionary Shares

‘Contrarian positioning’: 2 ASX shares to buy from an unloved sector

DNR Capital reveals the stocks that they have recently bought for cheap, going against market sentiment.

Read more »

Couple look at a bottle of wine while trying to decide what to buy.
Consumer Staples & Discretionary Shares

Should you pour Treasury Wine shares into your portfolio while they’re under $12?

Is this beaten-down stock in the $12 bargain bin?

Read more »

A woman screams and holds her hands up in frustration.
Consumer Staples & Discretionary Shares

Why is the Myer share price crashing 12% today?

Macroeconomic headwinds are starting to bite over at Myer.

Read more »

Smiling person with tattoos enjoying a glass of wine with a group of others.
Broker Notes

Could this be a very positive sign for Treasury Wine shares?

Will Chinese consumers soon be saying cheers to this company's wine again?

Read more »

A young woman sits at her desk in deep contemplation with her hand to her chin while seriously considering information she is reading on her laptop
Consumer Staples & Discretionary Shares

Should I still buy Wesfarmers shares at nearly $50 a pop?

Is Wesfarmers worth a pre-earnings buy at nearly $50 a share right now?

Read more »